Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Trimethylamine (TMA) is a short-chain tertiary aliphatic amine that is derived from the diet either directly from the consumption of foods high in TMA or by the intake of food high in precursors to TMA, such as trimethylamine-N-oxide (TMNO), choline and L-carnitine. The clinical significance of TMA may be related to its potential to contribute to neurological toxicity and 'uraemic breath' in patients with end-stage renal disease (ESRD). METHODS: Concentrations of TMA and TMNO in plasma from 10 healthy adults (not on haemodialysis) and 10 adults with ESRD undergoing haemodialysis (pre- and post-dialysis) were determined by gas chromatography-mass spectrometry. RESULTS: The concentrations of TMA and TMNO in pre-dialysis plasma (1.39+/-0.483 and 99.9+/-31.9 microM, respectively) were significantly (P<0.05) higher than the corresponding levels in healthy subjects (0.418+/-0.124 and 37.8+/-20.4 microM, respectively). However, there were no significant differences between post-dialysis and healthy subject plasma concentrations. In the ESRD patients, there was a significant (P<0.05) reduction in plasma TMA (from 1.39+/-0.483 to 0.484+/-0.164 microM) and TMNO (from 99.9+/-31.9 to 41.3+/-18.8 microM) during a single haemodialysis session. CONCLUSIONS: TMA and TMNO accumulate between haemodialysis sessions in ESRD patients, but are efficiently removed during a single haemodialysis session.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMAO is cleared by the kidney, and prior studies have reported TMAO is elevated in subjects with impaired renal function16–18.”
In the citing paper
“TMAO is cleared by the kidney, and prior studies have reported TMAO is elevated in subjects with impaired renal function16–18.”
In the citing paper
“Differences in characteristics and disease status of participants across studies might affect TMAO levels14, 27, 28 and therefore partly explain such inconsistency.”
From Gut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta‐Analysis of Prospective Studies (2017) · cites this paper as [28]
In the citing paper
“Serum concentration of TMAO was inversely associated with eGFR and was markedly higher in patients receiving dialysis (59,81); hemodialysis efficiently removed TMAO from blood (8).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [8]
In the citing paper
“Significantly higher concentrations of TMA and TMAO were noted in plasma from 15 patients with end-stage renal disease compared to 15 healthy counterparts (8).”
From Trimethylamine N -Oxide, the Microbiome, and Heart and Kidney Disease (2017) · cites this paper as [8]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Review on uremic toxins: Classification, concentration, and interindividual variability
Vanholder, R., For the European Uremic Toxin Work Group (EUTox), De Smet, R., Glorieux, G., Argilés, A., Baurmeister, U., Brunet, P., Clark, W., Cohen, G., De Deyn, P. P., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00924.x · Cited by 1,720
Bressolle, F., Bromet-Petit, M., & Audran, M. (1996) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(96)00088-6 · Cited by 400 · cited 2×
“These results were within reasonable limits for the measurement of endogenous compounds [10].”
BackgroundMethodLang, D., Yeung, C., Peter, R., Ibarra, C., Gasser, R., Itagaki, K., Philpot, R., & Rettie, A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00218-4 · Cited by 303
Trimethylaminuria: the fish malodor syndrome.
Mitchell, S. C., & Smith, R. L. (2001) · PubMed · Cited by 249
Biochemical Profile of Uremic Breath
Simenhoff, M. L., Burke, J. F., Saukkonen, J. J., Ordinario, A. T., Doty, R., & Dunn, S. (1977) · New England Journal of Medicine · doi:10.1056/nejm197707212970303 · Cited by 246 · cited 3×
“TMA and TMNO are of clinical importance because of their possible contribution to neurotoxicity and ‘uraemic breath’ in patients with ESRD [ 7 ].”
BackgroundMethodResultInfluentialDietary Precursors of Trimethylamine in Man: A Pilot Study
Zhang, A. Q., Mitchell, S. C., & Smith, R. L. (1999) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(99)00028-9 · Cited by 232 · cited 2×
“TMA may be derived from the diet either directly by the consumption of foods high in TMA, such as fish, or by the enterobacterial generation of TMA from food rich in trimethylamine-N -oxide (TMNO), choline or L -carnitine [1].”
BackgroundApproaches to Cancer Prevention Based on an Understanding of N-Nitrosamine Carcinogenesis
Hecht, S. S. (1997) · Experimental Biology and Medicine · doi:10.3181/00379727-216-44168 · Cited by 198 · cited 3×
“N -nitrosodimethylamine does not elicit its carcinogenic effects directly, but requires metabolic activation in the liver, particularly by the cytochrome P450 2E1 isoenzyme, to form highly reactive alkylating intermediates that have the ability to methylate target organ DNA [18].”
BackgroundResultInfluentialThe metabolism of14C-labelled trimethylamine and its N-oxide in man
Al-waiz, M., Mitchell, S. C., Idle, J. R., & Smith, R. L. (1987) · Xenobiotica · doi:10.3109/00498258709043962 · Cited by 143
Mills, G. A., Walker, V., & Mughal, H. (1999) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(98)00542-8 · Cited by 103 · cited 1×
“The plasma samples were analysed for TMA and TMNO using SPME and GC–MS based on the methods described previously [8,9].”
MethodIncreased incidence of neoplasia in chronic renal failure (20-year experience)
Cengiz, K. (2002) · International Urology and Nephrology · doi:10.1023/a:1014489911153 · Cited by 90 · cited 1×
“Other studies have shown higher levels of N -nitrosodimethylamine in the gastrointestinal tract of patients with ESRD compared with healthy controls [16] and, therefore, its potential contribution to an increased incidence of cancer in ESRD patients [17] should be carefully examined.”
Cited by
Items 101–200 of 293
Grabowska-Polanowska, B., Mochalski, P., Śliwka, I., & Amann, A. (2010) · Journal of Breath Research · doi:10.1088/1752-7155/4/2/026002 · Cited by 59
“For urine, the DMA concentration in healthy humans is about 17 mg l−1 and the concentration of TMA was estimated to be below 393 μg l−1 [16, 17].”
Microbiota-mediated metabolic perturbations in the gut and brain of mice after microplastic exposure
Lee, S.-H., Lin, W., & Cheng, T. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.141026 · Cited by 54
Metabolomics and renal disease
Rhee, E. P. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000136 · Cited by 54
“It is unknown if these findings extend to ESRD, in which TMAO levels are elevated approximately threefold above normal [52].”
BackgroundTMAO Is Both a Biomarker and a Renal Toxin
Fogelman, A. M. (2015) · Circulation Research · doi:10.1161/circresaha.114.305680 · Cited by 47
Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
Liabeuf, S., Cheddani, L., & Massy, Z. A. (2018) · Toxins · doi:10.3390/toxins10060229 · Cited by 48
“The TMAO still accumulated between treatments but was efficiently removed by a single hemodialysis session [86].”
BackgroundWilcox, J. D., Skye, S. M., Graham, B., Zabell, A., Li, X. S., Li, L., Shelkay, S., Fu, X., Neale, S., OʼLaughlin, C., et al. (2021) · The American Journal of Medicine · doi:10.1016/j.amjmed.2021.03.016 · Cited by 48
Doty, A. C., Zhang, Y., Weinstein, D. G., Wang, Y., Choi, S. H., Qu, W., Mittal, S., & Schwendeman, S. P. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.11.008 · Cited by 49
TMAO and diabetes: from the gut feeling to the heart of the problem
Jaworska, K., Kuś, M., & Ufnal, M. (2025) · Nutrition and Diabetes · doi:10.1038/s41387-025-00377-8 · Cited by 49
Wiese, G. N., Biruete, A., Moorthi, R. N., Moe, S. M., Lindemann, S. R., & Gallant, K. M. H. (2020) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2020.04.007 · Cited by 49
Development of QCM Trimethylamine Sensor Based on Water Soluble Polyaniline
Li, G., Zheng, J., Ma, X., Sun, Y. K., Fu, J., & Wu, G. (2007) · Sensors · doi:10.3390/s7102378 · Cited by 44
“Trimethylamine is also of clinical interest because of its potential to contribute to neurological toxicity and ’uraemic breath’ in patients with end-stage renal disease [5].”
BackgroundMitchell, S. M., Milan, A. M., Mitchell, C. J., Gillies, N. A., D’Souza, R. F., Zeng, N., Ramzan, F., Sharma, P., Knowles, S. O., Roy, N. C., et al. (2019) · Nutrients · doi:10.3390/nu11092207 · Cited by 43
“Kidney function is an independent risk factor for CVD [54], and impaired renal function is correlated with elevated plasma TMAO concentrations [55,56].”
BackgroundNahok, K., Phetcharaburanin, J., Li, J. V., Silsirivanit, A., Thanan, R., Boonnate, P., Joonhuathon, J., Sharma, A., Anutrakulchai, S., Selmi, C. F., et al. (2021) · Nutrients · doi:10.3390/nu13061865 · Cited by 41
“The major part of TMA is enzymatically converted to the odourless trimethylamine-N-oxide (TMAO), and high TMAO plasma levels are associated with cardiovascular disease (CVD) [17], chronic kidney disease (CKD) [18] and diabetes [19].”
BackgroundGrīnberga, S., Dambrova, M., Latkovskis, G., Strēle, I., Konrāde, I., Hartmane, D., Sevostjanovs, E., Liepinsh, E., & Pugovičs, O. (2015) · Biomedical Chromatography · doi:10.1002/bmc.3477 · Cited by 42
ZnTe-coated ZnO nanorods: Hydrogen sulfide nano-sensor purely controlled by pn junction
Hiếu, N. M., Lam, D. V., Hiên, T. T., Chính, N. Đ., Quang, N. D., Hùng, N. M., Phuoc, C. V., Lee, S., Jeong, J., Kim, C., et al. (2020) · Materials & Design · doi:10.1016/j.matdes.2020.108628 · Cited by 40
Koppe, L., & Soulage, C. O. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.025 · Cited by 42
Grabowska-Polanowska, B., Skowron, M., Miarka, P., Pietrzycka, A., & Śliwka, I. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.05.030 · Cited by 38
Hanifa, M. A., Skott, M., Maltesen, R. G., Rasmussen, B. S., Nielsen, S. U., Frøkiær, J., Ring, T., & Wimmer, R. (2019) · Metabolomics · doi:10.1007/s11306-019-1569-3 · Cited by 41
Zhang, P., Zou, J., Chen, J., Tan, X. Y., Xiang, F., Shen, B., Hu, J.-C., Wang, J., Wang, Y., Yu, J., et al. (2020) · Renal Failure · doi:10.1080/0886022x.2020.1822868 · Cited by 38
“to those with normal renal function [28]; however, HD patients rapidly accumulate TMAO between dialysis sessions due to decreased excretion.”
BackgroundBordoni, L., Samulak, J. J., Sawicka, A. K., Pelikant‐Małecka, I., Radulska, A., Lewicki, Ł., Kalinowski, L., Gabbianelli, R., & Olek, R. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-75633-1 · Cited by 39
Amrein, M., Li, X. S., Walter, J. E., Wang, Z., Zimmermann, T., Strebel, I., Honegger, U., Leu, K., Schäfer, I., Twerenbold, R., et al. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-01992-6 · Cited by 41
Lee, J., Choi, J., Kwon, Y., Lee, D., Jung, H., Ryu, H., Cho, J., Ryu, D. H., Kim, Y.-L., & Hwang, G. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.05.018 · Cited by 43
Mohammadi, A., Vahabzadeh, Z., Jamalzadeh, S., & Khalili, T. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.06.006 · Cited by 38
Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease
Sapa, H., Gutiérrez, O. M., Shlipak, M. G., Katz, R., Ix, J. H., Sarnak, M. J., Cushman, M., Rhee, E. P., Kimmel, P. L., Vasan, R. S., et al. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.02.016 · Cited by 37
Inflammation and l-carnitine therapy in hemodialysis patients: a review
Khalatbari‐Soltani, S., & Tabibi, H. (2014) · Clinical and Experimental Nephrology · doi:10.1007/s10157-014-1061-3 · Cited by 41
Li, X., Huang, M., Song, J., Shi, X., Chen, X., Yang, F., Pi, J., Zhang, H., Xu, G., & Zheng, J. (2019) · Poultry Science · doi:10.3382/ps/pez260 · Cited by 39
Assessment of gut microbiota fecal metabolites by chromatographic targeted approaches
Fiori, J., Turroni, S., Candela, M., & Gotti, R. (2019) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2019.112867 · Cited by 37
Maksymiuk, K. M., Szudzik, M., Gawryś-Kopczyńska, M., Onyszkiewicz, M., Samborowska, E., Mogilnicka, I., & Ufnal, M. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03687-y · Cited by 34
“Besides, patients with end-stage renal failure show increased plasma TMAO levels, which decreases after hemodialysis [11].”
BackgroundAkiyama, Y., Takeuchi, Y., Kikuchi, K., Mishima, E., Yamamoto, Y., Suzuki, C., Toyohara, T., Suzuki, T., Hozawa, A., Ito, S., et al. (2012) · Toxins · doi:10.3390/toxins4111309 · Cited by 33
“In contrast to tryptophan, it has previously been reported that trimethylamine N-oxide accumulates in CKD patients [25].”
Crețoiu, D., Ionescu, R. F., Enache, R. M., Creţoiu, S. M., & Voinea, S. C. (2021) · Microorganisms · doi:10.3390/microorganisms9091913 · Cited by 34
“TMAO [18] Vitamin K [19] Inflammatory cytokines [20] Osteoprotegerin [21] Oxidative stress [22] Pyrophosphate [23] Free p-cresylsulphate [24] Fetuin-A [21] Serum calcium [22,23] Matrix Gla protein [21] Serum phosphate [22,23] Osteopontin [23] Serum PTH [22] Bone morphogenetic protein 7 [21] Serum FGF-23 [22] Bone morp…”
BackgroundFu, Y., Yao, J., Xu, W., Fan, T., He, Q., Zhu, D., Cao, H., & Cheng, J. (2015) · Polymer Chemistry · doi:10.1039/c4py01793e · Cited by 32
An Update of Urine and Blood Metabolomics in Chronic Kidney Disease
Kalantari, S., & Nafar, M. (2019) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0008 · Cited by 34
Gases as Uremic Toxins: Is There Something in the Air?
Jankowski, J., Westhof, T., Vaziri, N. D., Ingrosso, D., & Perna, A. F. (2014) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2014.02.006 · Cited by 31
“The earlier-mentioned study identified 4-heptanone as a VOC that appeared almost exclusively in the breath of participants undergoing hemodialysis.(20) It thereby differs from compounds such as ammonia, TMA, DMA, or acetoin that show increasing concentrations in patients with renal failure both with and without hemodi…”
BackgroundTrimethylamine-N-oxide acutely increases cardiac muscle contractility
Oakley, C. I., Vallejo, J. A., Wang, D. D., Gray, M., Tiede-Lewis, L. M., Shawgo, T., Daon, E., Zorn, G. L., Stubbs, J. R., & Wacker, M. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00507.2019 · Cited by 31
From heart failure and kidney dysfunction to cardiorenal syndrome: TMAO may be a bridge
Zhang, J., Zhu, P., Li, S., Gao, Y., & Xing, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1291922 · Cited by 31
Heinrich‐Sanchez, Y., & Vital, M. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2525403 · Cited by 32
“An association between circulating TMAO and kidney function was already established in 1991 [64] and has been substantiated over the years [65,66].”
Lan, H., Zhang, W., Smått, J., Koivula, R., Hartonen, K. M., & Riekkola, M. (2019) · Microchimica Acta · doi:10.1007/s00604-019-3523-5 · Cited by 29
Metabolomic profiling of the autosomal dominant polycystic kidney disease rat model
Toyohara, T., Suzuki, T., Akiyama, Y., Yoshihara, D., Takeuchi, Y., Mishima, E., Kikuchi, K., Suzuki, C., Tanemoto, M., Ito, S., et al. (2011) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0467-4 · Cited by 29
“Cationic compounds increased in Cy/? rats (Fig. 1a) c-Guanidinobutyrate (c-GBA) O NS Low limit Increased in rat F [16] Creatinine O O O O O G Anthranilate O Low limit Low limit D [17, 18] 3-Methylhistidine O O O O G [19, 20] Allantoin O O O G [21] Trimethylamine N-oxide O O O G [22] Pipecolate O NS F 5-Methyl-2-deoxyc…”
BackgroundSummers, S., Quimby, J. M., Phillips, R. K., Stockman, J. A., Isaiah, A., Lidbury, J. A., Steiner, J. M., & Suchodolski, J. S. (2020) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15634 · Cited by 31
“Fecal score (1-7) 2 (2) 2 (1-3) 2 (2-3)”
The Diversity, Composition, and Metabolic Pathways of Archaea in Pigs
Deng, F., Li, Y., Peng, Y., Wei, X., Wang, X., Howe, S. M., Yang, H., Xiao, Y., Li, H., Zhao, J., et al. (2021) · Animals · doi:10.3390/ani11072139 · Cited by 32
“For example, some species of 61 archaea have been reported to reduce Trimethylamine-N-oxide (TMAO), a harmful 62 product associated with several diseases[10], through methanogenesis.”
BackgroundHuman Milk Lipids and Small Metabolites: Maternal and Microbial Origins
Stinson, L. F., & George, A. D. (2023) · Metabolites · doi:10.3390/metabo13030422 · Cited by 31
Leukocyte–endothelial interaction in CKD
Sarakpi, T., Mesic, A., & Speer, T. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad135 · Cited by 30
“At the same time, reduced renal excretion enhances the accumulation of various uremic toxins such as indoxyl sulfate, p-crezyl, trimethylamine N-oxide (TMAO) and phenylacetylglutamine [121–124].”
BackgroundRestini, C. B. A., Fink, G. D., & Watts, S. W. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105273 · Cited by 27
“1159/000484623 [PubMed: 29130962] [25].”
BackgroundQiu, Z., Li, G., & An, T. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.146915 · Cited by 27
Utility of SIFT-MS to evaluate volatile organic compounds in nephropathic patients’ breath
Romani, A., Marrone, G., Celotto, R., Campo, M., Vita, C., Chiaramonte, C., Carretta, A., Daniele, N. D., & Noce, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-14152-7 · Cited by 26
Application and development of SERS technology in detection of VOC gases
Meng, X., Wang, Y., Song, X., Liu, Y., Xie, Y., Xu, L., Jian, Y., Qiu, L., Wang, X., & Lin, J. (2024) · Materials Chemistry Frontiers · doi:10.1039/d4qm00812j · Cited by 25
Chilloux, J., Brial, F., Everard, A., Smyth, D. R., Andrikopoulos, P., Zhang, L., Plovier, H., Myridakis, A., Hoyles, L., Moreno‐Navarrete, J. M., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01413-8 · Cited by 26
Chen, Q., Zheng, J., Liu, X., Zhang, X., Kang, W., Fang, L., & Zhou, M. (2020) · Applied Surface Science · doi:10.1016/j.apsusc.2020.146520 · Cited by 24
Veeravalli, S., Karu, K., Phillips, I. R., & Shephard, E. A. (2017) · MethodsX · doi:10.1016/j.mex.2017.09.004 · Cited by 29
Georgopoulou, G. A., Papasotiriou, M., Bosgana, P., de Lastic, A.-L., Koufou, E., Papachristou, E. C., Goumenos, D. S., Davlouros, P. A., Kourea, E. P., Zolota, V., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12020368 · Cited by 24
“…expression might be attributed to diverse factors in CKD. Chronic kidney disease leads to uremic toxins’ accumulation (indoxyl sulphate, indole-3 acetic acid, p-cresyl sulphate, trimethylamine/trimethylamine-N-oxide, and phenylacetylglutamine), which might affect TJ structure and function [30–33].”
BackgroundWang, J., Long, C., Zhang, H., Zhang, Y., Wang, H., Yue, H., Wang, X., Wu, S., & Qi, G. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.16472 · Cited by 28
“Plasma TMAO was determined as TMA after TiCl3 reduction [44].”
MethodMolecular breath analysis identifies the breathprint of renal failure
Demirjian, S. G., Paschke, K. M., Wang, X., Grove, D., Heyka, R. J., & Dweik, R. A. (2017) · Journal of Breath Research · doi:10.1088/1752-7163/aa7143 · Cited by 24
Pan, S., Zhao, D., Duan, S., & Chen, X. (2023) · International Urology and Nephrology · doi:10.1007/s11255-023-03500-9 · Cited by 22
Non-invasive detection of renal disease biomarkers through breath analysis
Khokhar, M. (2023) · Journal of Breath Research · doi:10.1088/1752-7163/ad15fb · Cited by 22
“However, no significant differences in post-dialysis [45].”
Ujlaki, G., Kovács, T., Vida, A., Kókai, E., Rauch, B., Schwarcz, S., Mikó, E., Janka, E. A., Sipos, A., Hegedűs, C., et al. (2023) · Molecules · doi:10.3390/molecules28155898 · Cited by 24
Dietary Protein and Fiber in End Stage Renal Disease
Sirich, T. L. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12315 · Cited by 22
“Trimethylamine N-oxide is another uremic solute whose production increases with higher protein intake (43,44).”
BackgroundFriedrich, N., Budde, K., Suhre, K., Völker, U., John, U., Felix, S. B., Kroemer, H. K., Grabe, H. J., Völzke, H., Nauck, M. A., et al. (2015) · Metabolomics · doi:10.1007/s11306-015-0795-6 · Cited by 22
“…on cardiovascular risk, TMAO causes alteration in cholesterol metabolism by suppressing the reverse cholesterol transport through gut microbiotadependent mechanisms (Koeth et al. 2013) and is further related to renal diseases (Bain et al. 2006) by counteracting the effects of increased urea levels.”
BackgroundUnveiling Selected Influences on Chronic Kidney Disease Development and Progression
Fularski, P., Czarnik, W., Frankenstein, H., Gąsior, M., Młynarska, E., Rysz, J., & Franczyk, B. (2024) · Cells · doi:10.3390/cells13090751 · Cited by 21
“Studies have shown that serum TMAO levels in individuals with impaired renal function are significantly higher than in healthy populations [75].”
BackgroundLatkovskis, G., Makarova, E., Mazule, M., Bondare, L., Hartmane, D., Cirule, H., Grīnberga, S., Ērglis, A., Liepinsh, E., & Dambrova, M. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13728 · Cited by 20
Samulak, J. J., Sawicka, A. K., Samborowska, E., & Olek, R. A. (2019) · Nutrients · doi:10.3390/nu11061322 · Cited by 20
“Moreover, at the beginning of this century, elevated plasma TMAO levels were detected in patients with chronic renal disease [21] and were suggested as a marker of ischemic kidney damage [22].”
BackgroundNeyer, P. J., Bernasconi, L., Fuchs, J. A., Allenspach, M., & Steuer, C. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23062 · Cited by 20
Flores-Guerrero, J. L., Osté, M. C. J., Baraldi, P. B., Connelly, M. A., Garcia, E., Navis, G. J., Bakker, S. J. L., & Dullaart, R. P. F. (2021) · Nutrients · doi:10.3390/nu13010262 · Cited by 20
Miao, L., Du, J., Chen, Z., Shi, D., & Qu, H. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.710567 · Cited by 22
Lian, H., Yang, W., Yang, P., Zhang, X., & Zhang, A. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2145971 · Cited by 19
“However, it accumulates between HD sessions in HD patients [19].”
BackgroundWeinert, C. H., Empl, M. T., Krüger, R., Frommherz, L., Egert, B., Steinberg, P., & Kulling, S. E. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600651 · Cited by 21
Clinical Taste Perception Test for Patients With End-Stage Kidney Disease on Dialysis
Márquez-Herrera, R. M., Núñez-Murillo, G. K., Ruíz-Gurrola, C. G., Gómez-García, E. F., González, C. N. O., Cortés–Sanabria, L., Cueto-Manzano, A. M., & Campos, E. R. (2019) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2019.02.003 · Cited by 19
Jafari, A., Khatami, M., Dashti‐Khavidaki, S., Lessan‐Pezeshki, M., Abdollahi, A., & Moghaddas, A. (2017) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2016.11.002 · Cited by 20
“Trimethylamine and trimethylamine-N-oxide possibly contribute in neurotoxicity and ‘‘uremic breath’’ in patients with ESRD,(64,65) but they are efficiently removed during a single hemodialysis session.(66) The increase in the plasma concentrations of trimethylamine-N-oxide may occur after administration of more than 2…”
BackgroundChakravorty, S., Archana, Lakshmi, G., Solanki, P. R., & Kumar, A. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.114164 · Cited by 18
Theoretical Investigation of N-Nitrosodimethylamine Formation from Nitrosation of Trimethylamine
Zhi, S., Liu, Y. D., & Zhong, R. G. (2009) · The Journal of Physical Chemistry A · doi:10.1021/jp9056219 · Cited by 18
Lee, S., Kim, D., Jin, C., & Yoo, H. H. (2010) · Bulletin of the Korean Chemical Society · doi:10.5012/bkcs.2010.31.02.483 · Cited by 18
Mulders, L. V., Broecke, E. V., Paepe, E. D., Mortier, F., Vanhaecke, L., & Daminet, S. (2025) · Veterinary Quarterly · doi:10.1080/01652176.2024.2447601 · Cited by 19
“Recent studies have also indicated a potential mechanistic link between TMAO and progressive renal dysfunction, highlighting an association between TMAO levels, renal tubulointerstitial fibrosis, and functional impairment (Bain et al. 2006; Gupta et al. 2020; Zhang et al. 2021).”
Lever, M., McEntyre, C. J., George, P. M., Slow, S., Elmslie, J. L., Lunt, H., Chambers, S. T., Parry‐Strong, A., & Krebs, J. D. (2014) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-014-6542-9 · Cited by 17
“Historically, elevated plasma concentrations of the betaine analog, trimethylamine N-oxide, have been associated with renal failure [26, 27].”
BackgroundInflammatory and deleterious role of gut microbiota-derived trimethylamine on colon cells
Jalandra, R., Makharia, G. K., Sharma, M., & Kumar, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1101429 · Cited by 17
“Some studies reported even lesser concentration of TMA in body fluid (21, 22).”
Backgroundvan der Laan, T., Kloots, T., Beekman, M., Kindt, A. S. D., Dubbelman, A.-C., Harms, A. C., van Duijn, C. M., Slagboom, P. E., & Hankemeier, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-48876-w · Cited by 19
Prokopienko, A. J., West, R. E., Schrum, D. P., Stubbs, J. R., Leblond, F. A., Pichette, V., & Nolin, T. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-52032-9 · Cited by 18
Thamizhanban, A., Sarvepalli, G. P., Lalitha, K., Prasad, Y. S., Subbiah, D. K., Das, A., Rayappan, J. B. B., & Nagarajan, S. (2020) · ACS Omega · doi:10.1021/acsomega.9b02733 · Cited by 17
Strategies for optimizing urea removal to enable portable kidney dialysis: A reappraisal
Shao, G., Himmelfarb, J., & Hinds, B. J. (2022) · Artificial Organs · doi:10.1111/aor.14185 · Cited by 16
Consumption of Fish in Chronic Kidney Disease – A Matter of Depth
Mafra, D., Kemp, J. A., Leal, V. D. O., Cardozo, L., Borges, N. A., Alvarenga, L., Teixeira, K. T. R., & Stenvinkel, P. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200859 · Cited by 17
Fu, Y., Gao, Y., Chen, L., He, Q., Zhu, D., Cao, H., & Cheng, J. (2014) · RSC Advances · doi:10.1039/c4ra08995b · Cited by 16
Chang, D., Xu, X., Yang, Z., Ma, T., Nie, J., & Dong, J. (2021) · Peritoneal Dialysis International · doi:10.1177/08968608211051809 · Cited by 16
Subramaniam, S., Boukhlouf, S., & Fletcher, C. (2019) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000838 · Cited by 15
Trimethylamine N-Oxide as a Novel Therapeutic Target in CKD
Tang, W. H. W. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050576 · Cited by 14
Sohouli, M. H., Lozovanu, O. D., Fatahi, S., & Hekmatdoost, A. (2022) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2022.06.006 · Cited by 17
Lei, Y., Xiong, G., Lei, D., Wu, H., Xu, P. H., Chen, L., Fang, Q., Wu, Y., Wu, Y., Li, X., et al. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2575434 · Cited by 13
Adsorption Dynamics of Uremic Toxins to Novel Modified Magnetic Nanoparticles
Li, S., Sharaf, M. G., Zhang, L., Wishart, D. S., Tonelli, M. A., & Unsworth, L. D. (2023) · Macromolecular Bioscience · doi:10.1002/mabi.202300133 · Cited by 13
Urinary Metabolomics in Young Soccer Players after Winter Training Season
Kim, H. Y., Lee, J.-D., Lee, Y.-H., Seo, S.-W., Lee, H.-S., Kim, S., & Kim, K. (2022) · Metabolites · doi:10.3390/metabo12121283 · Cited by 14
“lation of trimethylamine in urine [39].”
Garg, B., Lei, S., Liu, S.-C., Bisht, T., Liu, J.-Y., & Ling, Y. (2012) · Analytica Chimica Acta · doi:10.1016/j.aca.2012.10.055 · Cited by 12
Yu, N., Gu, N., Wang, Y., Zhou, B., Lu, D., Li, J., Ma, X., Zhang, J., & Guo, X. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s339698 · Cited by 13
“In addition, TMAO is cleared by the kidney and linked to renal dysfunction.(15,16) Diabetic kidney disease (DKD), one of the most common microvascular complications of diabetes, is the major cause of impaired kidney function in diabetic subjects,(17) and may lead to the elevated circulating TMAO.”
BackgroundTrimethylamine N-Oxide as a Potential Risk Factor for Non-communicable Diseases: A Systematic Review
Tavassol, Z. H., Ejtahed, H., Larijani, B. A., & Hasani‐Ranjbar, S. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666221103120410 · Cited by 13
Pattern recognition analysis for 1H NMR spectra of plasma from hemodialysis patients
Fujiwara, M., Kobayashi, T., Jomori, T., Maruyama, Y., Oka, Y., Sekino, H., Imai, Y., & Takeuchi, K. (2009) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-009-2830-9 · Cited by 12
“TMAO accumulation in the end-stage-kidney disease [16] and its clearance by dialysis have already been reported [ 25 ].”
BackgroundPyatchenkov, M. O., Markov, A. G., & Rumyantsev, A. S. (2022) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2022-26-1-10-26 · Cited by 11
Devi, G. S., Manasa, M. V., & Vanaja, A. (2020) · Materials Science and Engineering B · doi:10.1016/j.mseb.2020.114629 · Cited by 11
Kromke, M., Palomino‐Schätzlein, M., Mayer, H., Pfeffer, S., Pineda‐Lucena, A., Luy, B., Hausberg, M., & Muhle‐Goll, C. (2016) · Translational research · doi:10.1016/j.trsl.2016.02.003 · Cited by 12
Cardiovascular Mortality in Chronic Kidney Patients: the Role of Uremic Toxins
Storino, G. F., Moraes, C. R., Saldanha, J. F., & Mafra, D. (2015) · International Journal of Cardiovascular Sciences · doi:10.5935/2359-4802.20150047 · Cited by 11
Gut Feelings About Heart Failure∗
Cannon, J. A., & McMurray, J. J. V. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.088 · Cited by 12
“In addition, the strong correlation between TMAO concentration and kidney function raises the following question: given the importance of the kidney in eliminating TMAO, is higher TMAO level just a marker of renal impairment (7)? Other questions arise—for example, what is the role of comorbidities, such as diabetes, i…”
BackgroundFMO3 deficiency of duck leads to decreased lipid deposition and increased antibacterial activity
Li, X., Song, J., Shi, X., Huang, M., Liu, L., Yi, G., Yang, N., Xu, G., & Zheng, J. (2022) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-022-00777-1 · Cited by 10
“TMA quantification TMA content was quantified using HS-GC as described previously with minor modifications [16, 22, 23].”
MethodLever, M., McEntyre, C. J., George, P. M., Slow, S., Chambers, S. T., & Foucher, C. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.04.001 · Cited by 10
Effect of l-carnitine supplementation on muscle cramps induced by stroke: A case report
Miwa, T., Hanai, T., Morino, K., Katsumura, N., & Shimizu, M. (2019) · Nutrition · doi:10.1016/j.nut.2019.110638 · Cited by 10
Structures of the TetR ‐like transcription regulator RcdA alone and in complexes with ligands
Pietrzyk‐Brzezinska, A. J., & Cociurovscaia, A. (2021) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26183 · Cited by 10
“For example, the levels of TMAO in plasma of patients suffering from chronic kidney disease (CKD) and of healthy subjects are 99.9 ± 31.9 mM and 37.8 ± 20.4 mM, respectively, according to Bain et al.56 Another example is the study of the adaptation of anaerobic E. coli cultures in response to environmental TMAO.”
MethodInfluentialAdsorption Dynamics of Uremic Toxins to Cyclodextrin-Coated Magnetic Nano-Adsorbents
Sharaf, M. G., Li, S., Tonelli, M. A., & Unsworth, L. D. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.122573 · Cited by 9
Işık, B., Çakar, F., Cankurtaran, O., & Cankurtaran, H. (2021) · ChemistrySelect · doi:10.1002/slct.202100638 · Cited by 9
Metadata
- Authors
- Bain, M. A., Faull, R., Fornasini, G., Milne, R. W., & Evans, A. M.
- Affiliations
- University of South Australia (AU)
- Corresponding author
- Bain, Marcus A.
- Venue
- Nephrology Dialysis Transplantation
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-09
- Volume
- 21
- Issue
- 5
- Pages
- 1300-1304
- ISSN
- 0931-0509 (ISSN-L)
- 1460-2385
- OpenAlex
- W2117368544
- Cited by
- 282
- References
- 20
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 13 · 2023: 16 · 2022: 32 · 2021: 22 · 2020: 20 · 2019: 26 · 2018: 17 · 2017: 20 · 2016: 19 · 2015: 21 · 2014: 19 · 2013: 6 · 2012: 6
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nephrology Dialysis Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- trimethylamine, trimethylamine N-oxide, end-stage renal disease, hemodialysis, plasma accumulation, neurotoxicity, choline, L-carnitine, dialysis clearance
- MeSH terms
- Adult, Female, Follow-Up Studies, Renal Dialysis, Humans, Kidney Failure, Chronic, Kidney Function Tests, Male, Methylamines, Middle Aged, Probability, Reference Values, Sensitivity and Specificity, Severity of Illness Index, Biomarkers, Case-Control Studies, Disease Progression, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.